UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea

Frontiers in pharmacology, 2022-05, Vol.13, p.884769-884769

2022

Volltextzugriff (PDF)

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Frontiers in pharmacology, 2020-07, Vol.11, p.970-970

2020

Volltextzugriff (PDF)

Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea

BMC public health, 2020-06, Vol.20 (1), p.1-1035, Article 1035

2020

Volltextzugriff (PDF)

Impact and challenges of enactment for advanced regenerative medicine in South Korea

Frontiers in bioengineering and biotechnology, 2022-10, Vol.10, p.972865-972865

2022

Volltextzugriff (PDF)

Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea

Journal of Korean Medical Science, 2021, 36(29), , pp.1-11

2021

Volltextzugriff (PDF)

How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements

BMC health services research, 2021-09, Vol.21 (1), p.1-967, Article 967

2021

Volltextzugriff (PDF)

Corporate social responsibility of pharmaceutical industry in Korea

Frontiers in pharmacology, 2022-08, Vol.13, p.950669-950669

2022

Volltextzugriff (PDF)

Relationship of ceramide–, and free fatty acid–cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins

Journal of dermatological science, 2015-01, Vol.77 (1), p.71-74

2015

Volltextzugriff (PDF)

Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate

Frontiers in pharmacology, 2020-03, Vol.11, p.232-232

2020

Volltextzugriff (PDF)

Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement

Frontiers in bioengineering and biotechnology, 2021-08, Vol.9, p.737504-737504

2021

Volltextzugriff (PDF)

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Frontiers in public health, 2021-06, Vol.9

2021

Volltextzugriff (PDF)

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy

International journal of environmental research and public health, 2022-09, Vol.19 (19), p.12366

2022

Volltextzugriff (PDF)

Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study

Journal of epidemiology, 2012, Vol.22 (6), p.508-516

2012

Volltextzugriff (PDF)

Analysis of Statistical Methods Currently used in Toxicology Journals

한국독성학회지, 2014, 30(3), , pp.185-191

2014

Volltextzugriff (PDF)

Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children

International journal of environmental research and public health, 2020-06, Vol.17 (12), p.4496

2020

Volltextzugriff (PDF)

Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea

International journal of environmental research and public health, 2022-02, Vol.19 (5), p.2494

2022

Volltextzugriff (PDF)

Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-03, Vol.38 (2), p.301-311

2024

Volltextzugriff (PDF)

Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-03, Vol.38 (2), p.323-323

2024

Volltextzugriff (PDF)

Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-01, Vol.38 (1), p.133-144

2024

Volltextzugriff (PDF)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs

International journal of environmental research and public health, 2022-04, Vol.19 (7), p.4204

2022

Volltextzugriff (PDF)

Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System

Clinical therapeutics, 2020-07, Vol.42 (7), p.1222-1233

2020

Volltextzugriff (PDF)

Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data

International journal of environmental research and public health, 2021-04, Vol.18 (8), p.4106

2021

Volltextzugriff (PDF)

The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea

International journal of environmental research and public health, 2022-09, Vol.19 (17), p.11100

2022

Volltextzugriff (PDF)

Response to Letter to the Editor on our paper “Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4” by Ha et al. (Submitted 25 Jun 2017)

Regulatory toxicology and pharmacology, 2018-04, Vol.94, p.325-329

2018

Volltextzugriff (PDF)

The Burden of Cervical Cancer in Korea: A Population-Based Study

International journal of environmental research and public health, 2020-08, Vol.17 (17), p.6308

2020

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(76)
Humans
(34)
Technology
(22)
Pharmacology & Pharmacy
(20)
Environmental Sciences
(16)
Environmental Sciences & Ecology
(16)
Female
(15)
Republic Of Korea
(15)
Health Insurance
(14)
Patients
(13)
Public, Environmental & Occupational Health
(13)
Toxicology
(13)
Male
(12)
Materials Science
(11)
Engineering
(10)
Health Care Sciences & Services
(10)
Materials Science, Multidisciplinary
(10)
Physical Sciences
(10)
Drugs
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea

Impact and challenges of enactment for advanced regenerative medicine in South Korea

Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea

How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements

Corporate social responsibility of pharmaceutical industry in Korea

Relationship of ceramide–, and free fatty acid–cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins

Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate

Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy

Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study

Analysis of Statistical Methods Currently used in Toxicology Journals

Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children

Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea

Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study

Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries

Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs

Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System

Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data

The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea

Response to Letter to the Editor on our paper “Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4” by Ha et al. (Submitted 25 Jun 2017)

The Burden of Cervical Cancer in Korea: A Population-Based Study

Suchergebnisse filtern